StockNews.com Initiates Coverage on Intra-Cellular Therapies (NASDAQ:ITCI)
Analysts at StockNews.com initiated coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a report released on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently commented on the stock. Baird R W downgraded shares of Intra-Cellular Therapies from a “strong-buy” rating […]
More Stories
Take Charge of My Heart: Release Date, Trailer, Plot, and More
Are you also hunting for the next Korean romantic-comedy drama? Then your search ends here. Take Charge of My Heart...
Minerva Academy: Release Date, Plot, Cast, Trailer, and More
Netflix’s latest Italian drama Minerva Academy is currently streaming online on the popular streaming network Netflix. Its original title is...
8 Best Commercial Skylight Companies for US Projects (2026)
Getting commercial daylighting wrong is expensive in a way residential work rarely is. A leaking curb on a house is...
Is Sweet Magnolias Season 6 Renewed? Latest News and Review
Netflix’s romantic drama Sweet Magnolias has finally come to an end. In September 2026, Deadline officially announced that one of...
The Inbetweeners 3: Release Date, Cast, Trailer, and Updates
The Inbetweeners 3 is finally coming back on the popular streaming Network, Netflix. The original four stars of the series,...
7 Essential Components of a Modern Corporate Training Tech Stack
What the seven components need to accomplish Your LMS isn’t obsolete. It may simply need to play one part in...